Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Metabasis Signs AMPK Deal With Merck Worth Up To $74M

June 28, 2005

By Jennifer Boggs

Metabasis Signs AMPK Deal With Merck Worth Up To $74M

June 28, 2005

By Jennifer Boggs

Salix Plans To Acquire InKine In Stock Deal Valued at $190M

June 27, 2005

By Jennifer Boggs

Salix Plans To Acquire InKine In Stock Deal Valued at $190M

June 27, 2005

By Jennifer Boggs

Amoxicillin Pulsys Misses In Phase III Trial; Advancis Falls

June 17, 2005

By Jennifer Boggs

Immtech's SPA Set For Pivotal Trial Of Anti-Infective Product

June 17, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...